Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxidation . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114230468A reveals a green SBA-15 catalytic route for nitrobenzaldehyde. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN115850252A discloses a novel iron-iodine co-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN111393427A reveals a safer, high-yield synthesis for pyroxasulfone intermediates, offering significant cost reduction and supply chain reliability for global herbicide manufacturers.
Novel catalytic oxidation method improves yield to 38% for Pyroxasulfone, offering cost-effective agrochemical intermediate manufacturing solutions.
Patent CN106928191B reveals improved Lansoprazole production with higher purity and yield. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104910079B reveals efficient one-pot oxidation for 4(3H)-quinazolinone derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel one-pot method for Imatinib intermediate reduces toxicity and improves yield for pharmaceutical manufacturing supply chains.
Patent CN1241914C details an efficient method for 7-quinolinyl-3,5-dihydroxyhept-6-enoate, offering superior purity and scalable production for HMG-CoA inhibitor manufacturing.
Patent CN107011133B reveals a green nitrite-catalyzed method for oxidizing benzylic C-H bonds to ketones, offering cost reduction in API manufacturing without metal residues.
Patent CN103930410B reveals iron-catalyzed epoxidation for high-purity DVBDO. Achieve cost reduction in epoxy resin manufacturing with scalable methods.
Novel dehydration-epoxidation route for Delta9,11-canrenone achieves >80% yield. Reduces steps vs fermentation. Ideal for eplerenone manufacturing.
Patent CN108659043B details a cost-effective CAN-catalyzed route for E-alkenyl diphenylphosphines, offering superior atom economy and simplified purification for pharmaceutical intermediates.
Novel non-toxic route for 2-(3-cyano-4-isobutoxy phenyl)-4-methyl-thiazole-5-carboxylic acid avoiding cyanides and corrosive acids.
Novel TEMPO-catalyzed one-pot synthesis for high-purity brassinolide intermediates. Significantly reduces pollution and operational costs for agrochemical manufacturing.
Novel 4-step synthesis of antiviral intermediate Phthiobuzone reduces bromine usage and improves scalability for reliable pharmaceutical supply chains.
Novel manganese-catalyzed process for carfilzomib intermediates significantly reduces cost and waste. Reliable pharmaceutical intermediate supplier for global scale manufacturing.
Patent CN106854200B reveals high-purity Ceritinib synthesis. Optimized catalytic route ensures supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN113512569B details a green enzymatic route for Lopinavir intermediates. Achieve high purity and cost reduction in API manufacturing with our advanced biocatalytic solutions.
Novel electrochemical method for tazobactam key intermediate improves yield and reduces steps compared to traditional halogenation routes.
Advanced catalytic elimination and epoxidation method for 4β,5β-epoxy-Δ6-steren-3β-alcohol. High stereoselectivity, cost-effective route for steroidal API manufacturing.